Canterbury, United Kingdom

Rhona M Plews


Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1979-1984

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Rhona M Plews: Innovator in Pharmaceutical Chemistry

Introduction

Rhona M Plews is a distinguished inventor based in Canterbury, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antihypertensive agents. With a total of 6 patents to her name, her work has had a notable impact on medical science.

Latest Patents

Among her latest patents are the innovative compounds 4-Amino-6,7-dimethoxy-2-(4-heteroaryl-piperazino)quinazoline and 2,4-Diaminoquinazoline. These compounds are characterized by their unique formula, wherein R is a pyrimidinyl, pyrazinyl, pyridazinyl, or triazinyl group linked to the piperazine ring. They are also optionally substituted by various functional groups, including hydroxy, halogen, alkyl, and certain amino groups. These compounds are recognized for their use as antihypertensive agents and in pharmaceutical compositions containing them.

Career Highlights

Rhona M Plews is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to focus on innovative drug development, contributing to advancements in healthcare.

Collaborations

Throughout her career, Rhona has collaborated with notable colleagues, including Simon F Campbell and Kenneth Richardson. These collaborations have further enriched her research and development efforts in the pharmaceutical field.

Conclusion

Rhona M Plews stands out as a prominent inventor in pharmaceutical chemistry, with her innovative patents paving the way for advancements in antihypertensive treatments. Her contributions continue to influence the medical community and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…